The long-term treatment of social phobia with moclobemide

International Clinical Psychopharmacology

Volumn 11, Issue SUPPL. 3, 1996, Pages 83-88

  Versiani, M ^a   Nardi, A E ^a   Mundim, F D ^a   Pinto, S ^a   Saboya, E ^a   Kovacs, R ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Long term treatment; Moclobemide; Social phobia

Indexed keywords

MOCLOBEMIDE;

ADOLESCENT; ADULT; ANXIETY; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HEADACHE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; NAUSEA; PHASE 3 CLINICAL TRIAL; PHOBIA; PRIORITY JOURNAL; PSYCHOSOCIAL DISORDER;

ADOLESCENT; ADULT; BENZAMIDES; FEMALE; HEADACHE; HUMANS; MALE; MIDDLE AGED; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITORS; NAUSEA; PHOBIC DISORDERS; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 0029808731     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-199606003-00014     Document Type: Conference Paper

References (13)

1. Davidson JR, George LK (1993) The epidemiology of social phobia: findings from the Duke Epidemiologic Catchment Area study. Psychol Med 23:709-718.
2. Davidson JR, Pottas N, Richichi E, et al. (1993) Treatment of social phobia with clonazepam and placebo. J Clin Psychopharmacol 13:423-428.
3. Liebowitz MR, Gorman JM, Fyer AJ, Klein DF (1985) Social phobia: review of a neglected anxiety disorder. Arch Gen Psychiatry 42:729-736.
4. Liebowitz MR, Fyer AJ, Gorman JM, Campeas R, Lewin AL (1986) Phenelzine in social phobia. J Clin Psychopharmacol 6:93-98.
5. Liebowitz MR, Schneier F, Campeas R, et al. (1992) Phenelzine vs. atenolol in social phobia: a placebo controlled comparison. Arch Gen Psychiatry 49:290-300.
6. Merikangas KR, Angst J (1995) Comorbidity and social phobia: evidence from clinical, epidemiologic, and genetics studies. Eur Arch Psychiatry Clin Neurosci 244:297-303.
7. Myers JK, Weissman MM, Tischler GL, et al. (1984) Six month prevalence of psychiatric disorders in three countries. Arch Gen Psychiatry 41:959-967.
8. Spitzer R, Williams JB, Gibbon M (1987) Structured Clinical Interview for DSM-III-R (SCID I and II). New York: Biometrics Research Department, New York Psychiatric Institute.
9. Versiani M, Mundim FD, Nardi AE, Liebowitz MR (1988) Tranylcypromine in social phobia. J Clin Psychopharmacol 8:279-283.
10. Versiani M, Nardi AE, Mundim FD (1989) Social phobia [in Portuguese]. J Bras Psiquiatria 38:251-263.
11. Versiani M, Nardi AE, Figueira IL, Stabl M (1990) Tolerability of moclobemide: a new reversible inhibitor of monoamine oxidase: compared with other antidepressants and placebo. Acta Psychiatr Scand 360:24-28.
12. Versiani M, Nardi AE, Mundim FD, Alves AB, Liebowitz MR, Amrein R (1992) Pharmacotherapy of social phobia: a controlled study with moclobemide and phenelzine. Br J Psychiatry 161:353-360.
13. van Vliet IM, der Boer J, Westenberg HGM (1992) Psychopharmacological treatment of social phobia: clinical and biochemical effects of brofaromine, a selective MAO-A inhibitor. Eur Neuropsychopharmacol 2:21-29.